Cargando…

Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential

Colorectal cancer (CRC) is presently the second most prevalent global mortality-inducing cancer. CRC carcinogenesis is a multifactorial process involving internal genetic mutations and the external environment. In addition, non-neoplastic cell activities within tumor microenvironments for CRC develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Fang, Chen, Wan-Yuan, Ma, Jie, He, Xiang-Lei, Wang, Jian-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727260/ https://www.ncbi.nlm.nih.gov/pubmed/35071502 http://dx.doi.org/10.12998/wjcc.v10.i1.23

Ejemplares similares

Rab25 as a tumour suppressor in colon carcinogenesis
por: Goldenring, J R, et al.
Publicado: (2011)

Breast cancer in schizophrenia could be interleukin-33-mediated
por: Borovcanin, Milica M, et al.
Publicado: (2021)

Colorectal cancer carcinogenesis: From bench to bedside
por: Currais, Pedro, et al.
Publicado: (2022)

Cell competition in liver carcinogenesis
por: Marongiu, Fabio, et al.
Publicado: (2020)

The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019)

Ras and Raf pathways in epidermis development and carcinogenesis
por: Kern, F, et al.
Publicado: (2011)

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022)

Unraveling the Paradoxical Action of Androgens on Muscle Stem Cells
por: Seo, Ji-Yun, et al.
Publicado: (2019)

Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
por: Kanat, Ozkan, et al.
Publicado: (2019)

Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
por: Ma, Shi-Xun, et al.
Publicado: (2023)

Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis
por: Dean, J P, et al.
Publicado: (2008)

Obesity paradox in patients undergoing coronary intervention: A review
por: Patel, Nirav, et al.
Publicado: (2017)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

Recent insights into the role of NF-kappaB in ovarian carcinogenesis
por: Alvero, Ayesha B
Publicado: (2010)

Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
por: O’Rourke, Joanne Marie, et al.
Publicado: (2018)

Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
por: Schizas, Dimitrios, et al.
Publicado: (2018)

The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis
por: Occhiuto, Christopher J., et al.
Publicado: (2023)

Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
por: Gilbert, D C, et al.
Publicado: (2012)

Current progress on the endoscopic features of colorectal sessile serrated lesions
por: Wang, Rui-Gang, et al.
Publicado: (2023)

Confusion and prospects for carcinogenesis of gastric adenoma and dysplasia: What is the correct answer currently?
por: Kinami, Shinichi, et al.
Publicado: (2022)

Large eustachian valve fostering paradoxical thromboembolism: passive bystander or serial partner in crime?
por: Onorato, Eustaquio Maria
Publicado: (2021)

Emerging role of autophagy in colorectal cancer: Progress and prospects for clinical intervention
por: Ma, Tian-Fei, et al.
Publicado: (2023)

Bacterial pathogens encode suppressors of RNA-mediated silencing
por: Mosher, Rebecca A, et al.
Publicado: (2008)

Application of Newcastle disease virus in the treatment of colorectal cancer
por: Song, Hui, et al.
Publicado: (2019)

Interleukin-33/ Suppression of Tumorigenicity 2 in Renal Fibrosis: Emerging Roles in Prognosis and Treatment
por: Tan, Xiao-Yang, et al.
Publicado: (2022)

Quadrilateral plate fractures of the acetabulum: Classification, approach, implant therapy and related research progress
por: Zhou, Xue-Feng, et al.
Publicado: (2022)

Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis
por: Kosa, Peter, et al.
Publicado: (2011)

ASPP: a new family of oncogenes and tumour suppressor genes
por: Sullivan, A, et al.
Publicado: (2007)

PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis
por: Chen, Qiao Yi, et al.
Publicado: (2018)

Epigenetics provides a new generation of oncogenes and tumour-suppressor genes
por: Esteller, M
Publicado: (2006)

Advances on the Role and Applications of Interleukin-1 in Tuberculosis
por: Silvério, Diogo, et al.
Publicado: (2021)

A new, effective and high-yield approach for identifying liver tumor suppressors
por: Olgun, Esra, et al.
Publicado: (2009)

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
por: Pejnovic, Nada, et al.
Publicado: (2016)

Developments in the Dehydrogenative Electrochemical Synthesis of 3,3′,5,5′‐Tetramethyl‐2,2′‐biphenol
por: Gleede, Barbara, et al.
Publicado: (2021)

Oncologic aspects of the decision-making process for surgical approach for colorectal liver metastases progressing during chemotherapy
por: Araujo, Raphael L C, et al.
Publicado: (2022)

Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think
por: Lobry, Camille, et al.
Publicado: (2011)

Young-onset colorectal cancer: A review
por: Done, Joy Zhou, et al.
Publicado: (2021)

Progress of magnetic resonance imaging radiomics in preoperative lymph node diagnosis of esophageal cancer
por: Xu, Yan-Han, et al.
Publicado: (2023)

At the crossroads: AMP-activated kinase and the LKB1 tumor suppressor link cell proliferation to metabolic regulation
por: Kyriakis, John M
Publicado: (2003)

New progress in roles of nitric oxide during hepatic ischemia reperfusion injury
por: Zhang, Ya-Qi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3l9ahnkiu49o8supadsjkqjfip